Skip to content

Clinical trials

Completed Alzheimer Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: United States Clear all

1,170 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
200111
200213
200326
200423
200531
200632
200749
200839
200963
201046
201139
201241
201340
201439
201553
201656
201749
201871
201984
202071
202182
202269
202341
202440
202514
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,170

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer31
Eli Lilly and Company30
Avid Radiopharmaceuticals29
National Institute on Aging (NIA)28
Indiana University20
Emory University19
University of Washington18
Johns Hopkins University16
University of Wisconsin, Madison16
VA Office of Research and Development16

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease1,170
Dementia341
Cognitive Dysfunction222
Memory Disorders56
Psychomotor Agitation39
Dementia, Vascular35
Lewy Body Disease24
Neurodegenerative Diseases24
Central Nervous System Diseases22
Parkinson Disease22

Trials

Showing 1 to 25 of 1,170. Each trial links to its page on Pharma Observatory.

1,070 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.